Clinical trials
Active, not recruiting Glycogen Storage Disease Type II trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Gene Therapies | 2 |
| Sanofi | 2 |
| Amicus Therapeutics | 1 |
| Duke University | 1 |
| Genzyme, a Sanofi Company | 1 |
| Iris Plug | 1 |
| Medical University of Vienna | 1 |
| RTI International | 1 |
| Rigshospitalet, Denmark | 1 |
| Spark Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glycogen Storage Disease Type II | 12 |
| Glycogen Storage Disease Type V | 2 |
| Anemia, Sickle Cell | 1 |
| Angelman Syndrome | 1 |
| Aortic Stenosis, Supravalvular | 1 |
| Argininosuccinic Aciduria | 1 |
| Barth Syndrome | 1 |
| Biotinidase Deficiency | 1 |
| Canavan Disease | 1 |
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 1 |
Trials
Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.